Risk of invasive prostate cancer and prostate cancer death in relatives of patients with prostatic borderline or in situ neoplasia: a nationwide cohort study

The question of whether having a family history of prostatic borderline or in situ neoplasia (PBISN) is associated with an increased risk of invasive prostate cancer (PCa) or death from PCa remains unanswered. The objective of the current study was to provide an evidence-based risk estimation for th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Xu, Xing (VerfasserIn) , Fallah, Mahdi (VerfasserIn) , Tian, Yu (VerfasserIn) , Mukama, Trasias (VerfasserIn) , Sundquist, Kristina (VerfasserIn) , Sundquist, Jan (VerfasserIn) , Brenner, Hermann (VerfasserIn) , Kharazmi, Elham (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 22 July 2020
In: Cancer
Year: 2020, Jahrgang: 126, Heft: 19, Pages: 4371-4378
ISSN:1097-0142
DOI:10.1002/cncr.33096
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1002/cncr.33096
Verlag, lizenzpflichtig, Volltext: https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.33096
Volltext
Verfasserangaben:Xing Xu, Mahdi Fallah, Yu Tian, Trasias Mukama, Kristina Sundquist, Jan Sundquist, Hermann Brenner, and Elham Kharazmi
Beschreibung
Zusammenfassung:The question of whether having a family history of prostatic borderline or in situ neoplasia (PBISN) is associated with an increased risk of invasive prostate cancer (PCa) or death from PCa remains unanswered. The objective of the current study was to provide an evidence-based risk estimation for the relatives of patients with PBISN.
Beschreibung:Gesehen am 19.08.2020
Beschreibung:Online Resource
ISSN:1097-0142
DOI:10.1002/cncr.33096